Health Care - Spark Newswire

1 minute read

Sage Therapeutics – Biogen’s Zuranolone Tops Placebo In Reducing Depressive Symptoms

Today, 2:17 PM

Sage Therapeutics Inc (NASDAQ:SAGE) and Biogen Inc (NASDAQ: BIIB) have announced data from WATERFALL Phase 3 study evaluating zuranolone (SAGE-217/BIIB125) in patients with Major…

BIIB

1 minute read

Ampio Stock Jumps On Enrollment Expansion Of Mid-Stage COVID-19 Trial To India With Inhaled Ampion

By Vandana Singh

Today, 2:17 PM

Ampio Pharmaceuticals Inc (NYSE:AMPE) has received regulatory approval to expand enrollment of its AP-019 Phase 2 study to India, assessing inhaled…

AMPE

1 minute read

AstraZeneca’s Antibody Treatment Unsuccessful At Preventing Symptomatic COVID-19 Infection

By Vandana Singh

Today, 2:17 PM

AstraZeneca Plc (NASDAQ:AZN) reported data from the STORM CHASER Phase 3 trial showing that its long-acting antibody (LAAB) combination…

AZN

1 minute read

Daiichi Sankyo To Stop Testing Inhaled Nafamostat In COVID-19 Patients In Japan

By Vandana Singh

Today, 2:17 PM

Daiichi Sankyo Co Ltd (OTC:DSNKY) said it was halting the development of an existing drug for the treatment of COVID-19 without…

DSKYF

1 minute read

Yet Another Biogen’s Retinal Disease Gene Therapy Fails In Late-Stage Study

By Vandana Singh

Today, 2:17 PM

While basking in the glow of the approval for its Alzheimer’s treatment, Biogen Inc (NASDAQ:BIIB) announced that a gene therapy candidate…

BIIB

1 minute read

Novavax’s COVID-19 Vaccine, Flu Shot Co-administration Preserved Efficacy, Likely ‘Viable Strategy,’ Company Says

By Vandana Singh

Today, 2:17 PM

Novavax Inc (NASDAQ:NVAX) announced its experimental COVID-19 vaccine remained effective when coadministered with an approved flu shot. Researchers are interested in…

NVAX

2 minute read

5 Reasons Why Omega Healthcare Investors Is A Health Care REIT To Watch

By Kevin Vandenboss

Today, 2:17 PM

Omega Healthcare Investors (NYSE: OHI) is a health care REIT that owns a portfolio of skilled nursing and senior housing facilities that are triple-net leased to third-party operators.

OHI

4 minute read

Novavax Vs. Pfizer Vs. Moderna: How COVID-19 Vaccines Stack Up

By Shanthi Rexaline

Today, 2:17 PM

It was "better late than never" for Novavax, Inc. (NASDAQ: NVAX), as the biopharma finally got around to announcing interim results from the U.S. and Mexico leg of the Phase 3 study of NVX-CoV2371, its vaccine candidate against the novel coronavirus.

BNTX

1 minute read

Epizyme’s Multiple Myeloma Drug Candidate Inhibits Tumors In Animal Models

By Vandana Singh

Today, 2:17 PM

Epizyme Inc (NASDAQ:EPZM) has reported positive data from mouse studies for potential first-in-class therapy, EPZ-719, that targets the enzyme SETD2. The…

EPZM